PREX2 and melanoma: Functional significance was assessed using truncation mutants and non-synonymous point mutations of PREX2. In comparison to wild-type PREX2, the over-expressed mutants showed accelerated tumorigenicity suggesting that some melanoma cells may gain oncogenic activity through PREX2 mutations (Berger et al., 2012).